Dhaka, Bangladesh || Tuesday, 26 May 2026 || 11 Jyoishtho 1433
People with anaphylaxis history should not take Pfizer vaccine
Peoples Time Desk
Published : Saturday, 12 December, 2020 at 12:25 PM, Count : 659

People with anaphylaxis history should not take Pfizer vaccine

People with anaphylaxis history should not take Pfizer vaccine

Anyone with a history of anaphylaxis to medicine or food should not get the Pfizer-BioNTech vaccine, the United Kingdom’s medicine regulator said on Wednesday expanding its guidance on an earlier allergy warning about the shot. 

“Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer BioNTech vaccine,” June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA) said in a statement. 

“A second dose should not be given to anyone who has experienced anaphylaxis following administration of the first dose of this vaccine.” 

Meanwhile, a top US government scientist also said that if the US Food and Drug Administration (FDA) decides to approve the vaccine, it will probably ask people with a known history of severe allergic reactions to not take it. 

The UK became the first country in the world to begin vaccinations against COVID-19 this week, but after reports of three possible allergic reactions from people who had their shots on the first day of the mass vaccination programme warned those with a “significant allergic reaction” to vaccines, medicines or food should not get the inoculation. 

The earlier warning did not mention anaphylaxis, which is a severe and potentially life-threatening reaction to a trigger, usually foods including milk, nuts and shellfish, as well medicines like aspirin. Other triggers include bee stings and latex. 

Symptoms of anaphylaxis include feeling faint, having difficulty breathing and a fast heartbeat. A patient may also develop a rash. The reaction requires immediate treatment and many people who suffer severe allergies usually carry adrenaline auto-injectors.

The MHRA approved the Pfizer-BioNTech vaccine for emergency use last week, paving the way for the start of a UK-wide vaccination programme on Tuesday.

The agency said it was updating its guidance after two cases of anaphylaxis and one report of a possible allergic reaction following immunisation.  





« PreviousNext »






Editor: Dr. Kazi Ertaza Hassan
All right reserved
South Western Media Group



© Daily Peoples Time

News & Commercial Office:
93, Kazi Nazrul Islam Avenue, Kawran Bazar, Dhaka-1215
Phone: 88-02-41010087, 41010086, Fax: 88-02-41010085, Advertising: 88-02-41010084
E-mail: news@dailypeoplestime.com